Image Source: Unsplash
Here’s a stock I haven’t thought about in a long time: Covid-mega-beneficiary Moderna (MRNA), which seems to have a rock-solid price sealing at about $118.

More By This Author:
Air Products: A Compelling Short OpportunityThis Is How AI Destroys A Company
Utilities On Deck




Comments
Log in or sign up to join the conversation.